QL
VIR icon

Quarry LP’s Vir Biotechnology VIR Stock Holding History

Quarry LP’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$469 Buy
+46
New +$438 ﹤0.01% 2181
2025
Q1 		– Sell
-6,000
Closed -$44K – 2029
2024
Q4 		$44K Sell
6,000
-11,000
-65% -$86.8K 0.01% 832
2024
Q3 		$127K Buy
17,000
+15,303
+902% +$133K 0.03% 346
2024
Q2 		$15.1K Buy
+1,697
New +$16.3K ﹤0.01% 1183

Other funds holding VIR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GP
GSK plc London $602M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Quarry LP's VIR Position: Q2 2026 in Review

Quarry LP opened a new position in Vir Biotechnology (VIR) in Q2 2026: 46 shares worth $469. The stake represents ﹤0.01% of the portfolio and ranks #2181 among its holdings. This is a return to the name: Quarry LP previously reported a position in VIR as recently as Q4 2024.

Quarry LP first reported a position in VIR in Q2 2024 and has held it in 4 quarters since. The position peaked at $127K in Q3 2024. 238 funds tracked by Wall St. Rank hold VIR as of Q2 2026.

  • Quarry LP held 46 shares of Vir Biotechnology worth $469 as of Q2 2026.
  • Vir Biotechnology was a new Quarry LP position in Q2 2026.
  • Vir Biotechnology made up ﹤0.01% of Quarry LP's portfolio in Q2 2026, its #2181 holding.
  • Quarry LP first reported a position in Vir Biotechnology in Q2 2024 and has held it in 4 quarters since.
  • Quarry LP's Vir Biotechnology position peaked at $127K in Q3 2024.
  • 238 funds tracked by Wall St. Rank held Vir Biotechnology as of Q2 2026.

Based on Quarry LP's 13F filing for Q2 2026, filed 14 Aug 2026.